89 related articles for article (PubMed ID: 3677005)
1. Malignant lymphomas of follicular center cell origin in man. VI. Large cleaved cell lymphoma.
Stein RS; Magee MJ; Lenox RK; Cousar JB; Collins RD; Flexner JM; Ray W; Greer JP
Cancer; 1987 Dec; 60(11):2704-11. PubMed ID: 3677005
[TBL] [Abstract][Full Text] [Related]
2. Large-cell lymphomas: clinical and prognostic features.
Stein RS; Greer JP; Flexner JM; Hainsworth JD; Collins RD; Macon WR; Cousar JB
J Clin Oncol; 1990 Aug; 8(8):1370-9. PubMed ID: 2199623
[TBL] [Abstract][Full Text] [Related]
3. The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas.
Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
Ann Intern Med; 1988 Dec; 109(12):939-45. PubMed ID: 3057985
[TBL] [Abstract][Full Text] [Related]
4. Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan.
Dunn P; Kuo TT; Shih LY; Lin TL; Wang PN; Kuo MC; Tang CC
Acta Haematol; 2004; 112(4):203-8. PubMed ID: 15564732
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
7. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Lee AY; Connors JM; Klimo P; O'Reilly SE; Gascoyne RD
J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181
[TBL] [Abstract][Full Text] [Related]
8. Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
Tezcan H; Vose JM; Bast M; Bierman PJ; Kessinger A; Armitage JO
Leuk Lymphoma; 1999 Jul; 34(3-4):273-85. PubMed ID: 10439364
[TBL] [Abstract][Full Text] [Related]
9. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience.
Bennett JM; Cain KC; Glick JH; Johnson GJ; Ezdinli E; O'Connell MJ
J Clin Oncol; 1986 Oct; 4(10):1462-9. PubMed ID: 3531421
[TBL] [Abstract][Full Text] [Related]
10. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
Mac Manus MP; Hoppe RT
J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome and prognostic factors for primary nasal lymphoma.
Liang R; Todd D; Chan TK; Chiu E; Lie A; Kwong YL; Choy D; Ho FC
J Clin Oncol; 1995 Mar; 13(3):666-70. PubMed ID: 7884427
[TBL] [Abstract][Full Text] [Related]
12. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
[TBL] [Abstract][Full Text] [Related]
13. T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients.
Greer JP; Macon WR; Lamar RE; Wolff SN; Stein RS; Flexner JM; Collins RD; Cousar JB
J Clin Oncol; 1995 Jul; 13(7):1742-50. PubMed ID: 7602364
[TBL] [Abstract][Full Text] [Related]
14. Follicular non-Hodgkin's lymphoma in Hong Kong Chinese: a retrospective analysis.
Liang R; Todd D; Chan TK; Ng RP; Choy D; Loke SL; Ho FC
Hematol Oncol; 1988; 6(1):29-37. PubMed ID: 3343027
[TBL] [Abstract][Full Text] [Related]
15. Therapy of non-Hodgkin's lymphoma.
Coffey J; Hodgson DC; Gospodarowicz MK
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S28-36. PubMed ID: 12692688
[TBL] [Abstract][Full Text] [Related]
16. CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas.
Pan D; Qin J; Farber C; O'Brien J; Filippa D; Portlock CS
Leuk Lymphoma; 2003 Jun; 44(6):967-71. PubMed ID: 12854895
[TBL] [Abstract][Full Text] [Related]
17. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
19. Malignant lymphomas of follicular centre cell origin in man. VII. Prognostic features in small cleaved cell lymphoma.
Stein RS; Greer JP; Cousar JB; Hendey GW; Wehner JH; Flexner JM; Collins RD
Hematol Oncol; 1989; 7(5):381-91. PubMed ID: 2475420
[TBL] [Abstract][Full Text] [Related]
20. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
